TY  - GEN
TI  - KarXT+EC Phase 3 (NCT07011732): Enhanced Formulation for AD Agitation
AU  - Migration, Crosslink
PY  - 2026
UR  - https://scidex.ai/artifact/wiki-clinical-trials-karxt-nct07011732-ad-agitation
PB  - SciDEX
ER  -